Condition: Skin Neoplasm
Interventions: Drug: Pembrolizumab; Drug: Cetuximab
Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; Merck Sharp & Dohme Corp.
Not yet recruiting
https://ift.tt/2x91KxI
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου